Key result
Global statin prescription practices for patients with type 2 diabetes mellitus show significant variations, with frequent underutilization of high-intensity statins in high-risk patients despite clinical guidelines.
Why the study?
Global statin prescription practices for patients with T2DM often diverge from clinical guidelines, which can lead to suboptimal cardiovascular outcomes.
Systematic Review (n=119,302)
This systematic review highlights significant global underutilization of guideline-directed high-intensity statin therapy in patients with type 2 diabetes, emphasizing the need for improved physician education and guideline adherence.
Answers are grounded in this paper and cite their sources.
Global statin underprescription and intensity shortfalls persist in T2DM; supports targeted guideline implementation efforts and further adherence studies.
Cardiovascular disease (CVD) poses a significant risk for individuals with type 2 diabetes mellitus (T2DM), and statins are integral in preventing such complications. However, global statin prescription practices often diverge from clinical guidelines, which can lead to suboptimal cardiovascular outcomes. This review examines global trends in statin prescription patterns in T2DM management, focusing on adherence to clinical guidelines, gaps in statin utilization, and the impact on cardiovascular health. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses-2 guidelines, this systematic review analyzed eight studies on statin prescription trends, guideline adherence, and therapy intensity, revealing significant global variations in prescription practices. Notably, higher prescription rates were found in Asia compared to Africa and certain developed nations. Despite recommendations, high-intensity statins were underutilized globally, with many patients receiving moderate- or low-intensity therapy. Inappropriate statin use was also observed in low-risk T2DM patients, raising concerns about unnecessary exposure to potential adverse effects. The findings underscore the urgent need for improved adherence to clinical guidelines, particularly for high-risk T2DM patients, and highlight the importance of addressing these barriers. To optimize cardiovascular outcomes, the review emphasizes enhanced physician education, better implementation of guidelines, and targeted strategies to optimize statin therapy. Addressing these gaps could lead to a reduction in CVD risk and improved outcomes for patients with T2DM globally.
No takes yet. Share an insight, caveat, or question.
Besekar et al. (2025) conducted a systematic review in Type 2 diabetes mellitus (n=119,302). Statins was evaluated on Statin prescription rates and guideline adherence. Global statin prescription practices for patients with type 2 diabetes mellitus show significant variations, with frequent underutilization of high-intensity statins in high-risk patients despite clinical guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: